Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

News

Inflammation Associated With Cognitive Decline in Patients With Schizophrenia

Maria Asimopoulos

Inflammation may be linked to cognitive decline in patients with schizophrenia, leading study authors to encourage a better understanding of underlying pathways to improve outcomes for this patient population. The findings were published in Progress in Neuro-Psychopharmacology and Biological Psychiatry.

“Schizophrenia is a complex psychiatric disorder that includes positive and negative symptoms but also debilitating cognitive deficits. Current pharmacological interventions do not target these deficits,” wrote a research team from Ireland.

Seeking to address research gaps, investigators analyzed data from 25 studies to better understand the association between cognitive performance and the inflammatory markers Interleukin-6 (IL-6), IL-1β, Tumor Necrosis Factor-α (TNF-α), and C-reactive protein (CRP). The meta-analysis used PubMed and Web of Science databases and included 2398 patients.

There was a significant inverse relationship between systemic plasma levels of all 4 inflammatory markers and several measures of cognitive performance, including attention-processing speed, executive function, working memory, verbal and visual learning, and verbal and visual memory.

The significant decline in cognitive performance was associated with the following ranges for each biomarker:

  • -0.136 to -0.181 for IL-6;
  • -0.372 to -0.476 for IL-1β;
  • -0.188 to -0.38 for TNF-α; and
  • -0.168 to -0.311 for CRP.

Researchers concluded the findings suggest a relationship between inflammation and cognitive decline in patients with schizophrenia, with cognitive deficits reflecting elevated levels of proinflammatory biomarkers.

“Understanding the underlying pathways between them could have a significant impact on the disease progression and quality of life,” they said.

Reference:
Patlola SR, Donohoe G, McKernan DP. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. Published online October 22, 2022. doi:10.1016/j.pnpbp.2022.110668

Advertisement

Advertisement